Zhijie Wang

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Zhijie Wang, Jianchun Duan, Shangli Cai et al. · JAMA Oncology · 2019 · 495 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

Xiaohui Ni, Minglei Zhuo, Zhe Su et al. · Proceedings of the National Academy of Sciences · 2013 · 481 citations · Full text

Medicine, Genetics, Oncology +17

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

Jie Wang, Shun Lü, Xinmin Yu et al. · JAMA Oncology · 2021 · 398 citations · Full text

Medicine, Oncology, Pharmacology +16

TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer

Jiefei Han, Jianchun Duan, Hua Bai et al. · Cancer Immunology Research · 2019 · 277 citations

Medicine, Immunology, Oncology +17